200 related articles for article (PubMed ID: 3015384)
1. Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation.
Osterlind K; Andersen PK
Cancer Res; 1986 Aug; 46(8):4189-94. PubMed ID: 3015384
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in small cell lung cancer: multivariate analysis in the National Cancer Center Hospital (Japan).
Shinkai T; Sakurai M; Eguchi K; Sasaki Y; Tamura T; Fujiwara Y; Fukuda M; Yamada K; Kojima A; Sasaki S
Jpn J Clin Oncol; 1989 Jun; 19(2):135-41. PubMed ID: 2543848
[TBL] [Abstract][Full Text] [Related]
3. Determinants of complete remission induction and maintenance in chemotherapy with or without irradiation of small cell lung cancer.
Osterlind K; Hansen HH; Dombernowsky P; Hansen M; Andersen PK
Cancer Res; 1987 May; 47(10):2733-6. PubMed ID: 3032413
[TBL] [Abstract][Full Text] [Related]
4. Survival and prognostic factors in lung cancer patients treated in phase I trials: Japanese experience.
Yamamoto N; Tamura T; Fukuoka M; Saijo N
Int J Oncol; 1999 Oct; 15(4):737-41. PubMed ID: 10493956
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic factors in unresectable lung cancer].
Urata A
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2035-42. PubMed ID: 2840034
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
[TBL] [Abstract][Full Text] [Related]
7. Combined modality therapy of lung cancer.
Livingston RB
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2638-47. PubMed ID: 10068267
[TBL] [Abstract][Full Text] [Related]
8. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
Milman N; Pedersen LM
Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in inoperable adenocarcinoma of the lung: a multivariate regression analysis of 259 patients.
Sørensen JB; Badsberg JH; Olsen J
Cancer Res; 1989 Oct; 49(20):5748-54. PubMed ID: 2790789
[TBL] [Abstract][Full Text] [Related]
10. Multimodality treatment including early high-dose chemotherapy with peripheral blood stem cell transplantation in limited-disease small cell lung cancer.
Brugger W; Fetscher S; Hasse J; Frommhold H; Pressler K; Mertelsmann R; Engelhardt R; Kanz L
Semin Oncol; 1998 Feb; 25(1 Suppl 2):42-8. PubMed ID: 9535211
[TBL] [Abstract][Full Text] [Related]
11. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
12. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
Ardizzoni A; Cafferata MA; Paganuzzi M; Filiberti R; Marroni P; Neri M; Fontana V; Nicoló G; Perdelli L; Stampino CG; Rosso R; Puntoni R
Cancer; 2001 Oct; 92(7):1896-904. PubMed ID: 11745263
[TBL] [Abstract][Full Text] [Related]
13. A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer.
Badzio A; Kurowski K; Karnicka-Mlodkowska H; Jassem J
Eur J Cardiothorac Surg; 2004 Jul; 26(1):183-8. PubMed ID: 15200999
[TBL] [Abstract][Full Text] [Related]
14. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung.
Souhami RL; Bradbury I; Geddes DM; Spiro SG; Harper PG; Tobias JS
Cancer Res; 1985 Jun; 45(6):2878-82. PubMed ID: 2985256
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
Lee YC; McCrystal MR; Christmas TI
N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
[TBL] [Abstract][Full Text] [Related]
17. [Pre-therapeutic prognostic factors of survival in small cell bronchial cancer. Retrospective study in a series of 112 patients].
Quoix E; Hedelin G; Seibert R; Popin E; Dietemann A; Roeslin N; Pauli G
Rev Mal Respir; 1993; 10(1):29-34. PubMed ID: 8383869
[TBL] [Abstract][Full Text] [Related]
18. High pretreatment serum concentration of basic fibroblast growth factor is a predictor of poor prognosis in small cell lung cancer.
Ruotsalainen T; Joensuu H; Mattson K; Salven P
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1492-5. PubMed ID: 12433733
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors in patients with small cell lung cancer].
Song LH; Song XR; Zhang XQ; Qi JL; Li XJ; Tian H; Bu B
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):413-6. PubMed ID: 15355646
[TBL] [Abstract][Full Text] [Related]
20. High plasma D-dimer level is associated with decreased survival in patients with lung cancer.
Altiay G; Ciftci A; Demir M; Kocak Z; Sut N; Tabakoglu E; Hatipoglu ON; Caglar T
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):494-8. PubMed ID: 17513096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
